People with Type 2 diabetes (T2D) and an elevated risk for cardiovascular disease (CVD) who took low-dose aspirin were less ...
Q3 2025 Earnings Call Transcript October 28, 2025 Operator: Thank you for standing by. Welcome to the Kiniksa Pharmaceuticals ...
The clinical-stage CRISPR genome-editing company reported a 92% overall response rate and 75% complete response rate or better in a 12-patient cohort treated with the recommended dose for expansion.